Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

5AM Solutions and LABVANTAGE Announce Partnership

Published: Sunday, February 10, 2013
Last Updated: Sunday, February 10, 2013
Bookmark and Share
Partnership to provide consulting and implementation services

5AM announced that it is partnering with LABVANTAGE Solutions, an innovative provider of enterprise laboratory informatics software. 5AM will work closely with LABVANTAGE to provide consulting and implementation services in order to support current and future LABVANTAGE customers in government organizations, commercial organizations, and academic institutions.

The partnership will initially focus on meeting increasing customer demand for training, implementation, biobanking best practices, and data standardization. 5AM’s track record of integration and implementation expertise in the domains where biospecimens play a fundamental role combined with LABVANTAGE software will provide customers the ability to fully exercise the utility of the world’s leading LIMS software faster.

“We have admired each others’ progress for years and have discovered how we can add value together,” said Erica Marrari, Biospecimen Practice Lead at 5AM Solutions. “Doing what we each do best will allow us to serve the growing market need, delivering optimal value to customers who are at the core of translating science into medical benefit.”

“As we continue to experience significant growth in the Life Science LIMS and Biobanking space, we felt it was very important for us to expand and enhance our implementation capabilities by partnering with an organization that can offer strong domain expertise and proven best practices capabilities,” said Jerry Hacker, Sr. VP of Worldwide Sales at LABVANTAGE. “We are excited about this partnership and look forward to serving our customers in a manner that meets or exceeds their expectations.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More Than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Computational Model Finds New Protein-Protein Interactions
Researchers at University of Pittsburgh have discovered 500 new protein-protein interactions (PPIs) associated with genes linked to schizophrenia.
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Bioreactors Ready for the Big Time
Bioreactors are passive filtration systems that can reduce nitrate losses from farm fields.
Analysis of Dog Genome will Provide Insight into Human Disease
An important model in studying human disease, the non-coding RNA of the canine genome is an essential starting point for evolutionary and biomedical studies – according to a new study led by The Genome Analysis Centre (TGAC).
‘Mini-Brains’ to Study Zika
Novel tool expected to speed research on brain and drug development.
Finding Factors That Protect Against Flu
A clinical trial examining the body’s response to seasonal flu suggests new approaches for evaluating the effectiveness of seasonal flu vaccines.
New Insights into Gene Regulation
Researchers have solved the three-dimensional structure of a gene repression complex that is known to play a role in cancer.
Controlling RNA in Living Cells
Modular, programmable proteins can be used to track or manipulate gene expression.
Common Class of Cancer Drugs May Not Lead to Cognitive Decline
UCLA study refutes 2015 research suggesting anthracyclines could cause memory loss, other impairments.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!